Iron porphyrinate Fe(TPPS) reduces brain cell damage in rats intrastriatally lesioned by quinolinate

Neurotoxicology and Teratology

Volumn 30, Issue 6, 2008, Pages 510-519

  González Cortés, Carolina ^a   Salinas Lara, Citlaltepetl ^a   Gómez López, Marcos Artemio ^a   Tena Suck, Martha Lilia ^a   Pérez De La Cruz, Verónica ^a   Rembao Bojórquez, Daniel ^a   Pedraza Chaverrí, José ^b   Gómez Ruiz, Celedonio ^b   Galván Arzate, Sonia ^a   Ali, Syed F ^c   Santamaría, Abel ^a,c  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^b Universidad Nacional Autonoma de Mexico Facultad de Quimica   (Mexico)

^c NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Excitotoxicity; Inflammatory events; Oxidative nitrergic stress; Peroxynitrite

Indexed keywords

5,10,15,20 TETRAKIS (4 SULFONATOPHENYL)PORPHYRINATE IRON; BIOLOGICAL MARKER; GLIAL FIBRILLARY ACIDIC PROTEIN; GREEN FLUORESCENT PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; PEROXYNITRITE; QUINOLINIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN DAMAGE; BRAIN EDEMA; CATALYST; CELL ACTIVATION; CELL DAMAGE; CONTROLLED STUDY; CORPUS STRIATUM; DECOMPOSITION; EXCITOTOXICITY; GLIA CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SINGLE DRUG DOSE; WISTAR RAT;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN INJURIES; CELL DEATH; CORPUS STRIATUM; DRUG ADMINISTRATION SCHEDULE; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN-6; MALE; NEUROPROTECTIVE AGENTS; NITRIC OXIDE SYNTHASE TYPE II; PORPHYRINS; QUINOLINIC ACID; RATS; RATS, WISTAR;

ANIMALIA; RATTUS;

EID: 53249095787     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ntt.2008.05.004     Document Type: Article

References (25)

1. Aguilera P., Chanéz-Cárdenas M.E., Floriano-Sánchez E., Barrera D., Santamaría A., Sánchez-González D.J., Pérez-Severiano F., Pedraza-Chaverrí J., and Maldonado-Jiménez P.D. Time-related changes in constitutive and inducible nitric oxide synthases in the rat striatum in a model of Huntington's disease. Neurotoxicology 28 (2007) 1200-1207
2. Aschner M. Immune and inflammatory responses in the CNS: modulation by astrocytes. Toxicol. Lett. 102-103 (1998) 283-287
3. Brown G.C., and Bal-Price A. Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol. Neurobiol. 27 (2003) 325-355
4. Crow J.P. Peroxynitrite scavenging by metalloporphyrins and thiolates. Free Radic. Biol. Med. 28 (2000) 1487-1494
5. Fiebich B.L., Lieb K., Berger M., and Bauer J. Stimulation of the sphingomyelin pathway induces interleukin-6 gene expression in human astrocytoma cells. J. Neuroimmunol. 63 (1995) 207-221
6. González-Cortés C., and Santamaría A. Quinolinic acid, Huntington's disease and inflammatory events in the brain. In: Santamaría A., and Jiménez-Capdeville M.E. (Eds). New Perspectives on Brain Cell Damage, Neurodegeneration and Neuroprotective Strategies, Research Signpost, Kerala, India (2007) 37-60
7. Hooper D.C., Kean R.B., Scott G.S., Spitsin S.V., Mikheeva T., Morimoto K., Bette M., Röhrenbeck A.M., Dietzschold B., and Weihe E. The central nervous system inflammatory response to neurotropic virus infection is peroxynitrite dependent. J. Immunol. 167 (2001) 3470-3477
8. Imam S.Z., and Ali S.F. Aging increases the susceptibility to methamphetamine-induced dopaminergic neurotoxicity in rats: correlation with peroxynitrite production and hyperthermia. J. Neurochem. 78 (2001) 1-10
9. Imam S.Z., Islam F., Itzhak Y., Slikker Jr. W., and Ali S.F. Prevention of dopaminergic neurotoxicity by targeting nitric oxide and peroxynitrite: implications for the prevention of methamphetamine-induced neurotoxic damage. Ann. N.Y. Acad. Sci. 914 (2000) 157-171
10. Imam S.Z., Newport G.D., Itzhak Y., Cadet J.L., Islam F., Slikker Jr. W., and Ali S.F. Peroxynitrite plays a role in methamphetamine-induced dopaminergic neurotoxicity: evidence from mice lacking neuronal nitric oxide synthase gene or over expressing copper-zinc superoxide dismutase. J. Neurochem. 76 (2001) 745-749
11. Lancel S., Tissier S., Mordon S., Marechal X., Depontieu F., Scherpereel A., Chopin C., and Neviere R. Peroxynitrite decomposition catalysts prevent myocardial dysfunction and inflammation in endotoxemic rats. J. Am. Coll. Cardiol. 43 (2004) 2348-2358
12. Misko T.P., Highkin M.K., Veenhuizen A.W., Manning P.T., Stern M.K., Currie M.G., and Salvemini D. Characterization of the cytoprotective action of peroxinitrite decomposition catalysts. J. Biol. Chem. 273 (1998) 15646-15653
13. Noack H., Lindenau J., Rothe F., Asayama K., and Wolf G. Differential expression of superoxide dismutase isoforms in neuronal and glial compartments in the course of excitotoxically mediated neurodegeneration: relation to oxidative and nitrergic stress. Glia 23 (1998) 285-297
14. Paxinos G., and Watson G. The Rat Brain in Stereotaxic Coordinates (1998), Academic Press, New York
15. Pérez-De La Cruz V., and Santamaría A. Integrative hypothesis for Huntington's disease: a brief review of experimental evidence. Physiol. Res. 56 (2007) 513-526
16. Pérez-De La Cruz V., González-Cortés C., Galván-Arzate S., Medina-Campos O.N., Pérez-Severiano F., Ali S.F., Pedraza-Chaverrí J., and Santamaría A. Excitotoxic brain damage involves early peroxynitrite formation in a model of Huntington's disease in rats: protective role of iron porphyrinate 5,10,15,20-tetrakis (4-sulfonatophenyl)porphyrinate iron (III). Neuroscience 135 (2005) 463-474
17. Rodríguez E., Méndez-Armenta M., Villeda-Hernández J., Galván-Arzate S., Barroso-Moguel R., Rodríguez F., Ríos C., and Santamaría A. Dapsone prevents morphological lesions and lipid peroxidation induced by quinolinic acid in rat corpus striatum. Toxicology 139 (1999) 111-118
18. Rodríguez-Martínez E., Camacho A., Maldonado P.D., Pedraza-Chaverrí J., Santamaría D., Galván-Arzate S., and Santamaría A. Effect of quinolinic acid on endogenous antioxidants in rat corpus striatum. Brain Res. 858 (2000) 436-439
19. Ryu J.K., Choi H.B., and McLarnon J.G. Peripheral benzodiazepine receptor ligand PK11195 reduces microglial activation and neuronal death in quinolinic acid-injected rat striatum. Neurobiol. Dis. 20 (2005) 550-561
20. Salvemini D., Wang Z.Q., Stern M.K., Currie M.G., and Misko T.P. Peroxynitrite decomposition catalysts: therapeutics for peroxynitrite-mediated pathology. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 2659-2663
21. Santamaría D., Espinoza-González V., Ríos C., and Santamaría A. Nω-nitro-l-arginine, a nitric oxide synthase inhibitor, antagonizes quinolinic acid-induced neurotoxicity and oxidative stress in rat striatal slices. Neurochem. Res. 24 (1999) 843-848
22. 2A receptor antagonist. J. Neurosci. Res. 85 (2007) 1077-1085
23. Tardy M., Fages C., Le Prince G., Rolland B., and Nunez J. Regulation of the glial fibrillary acidic protein (GFAP) and of its encoding mRNA in the developing brain in cultured astrocytes. Adv. Exp. Med. Biol. 265 (1990) 41-52
24. Torreilles F., Salman-Tabcheh S., Guérin M., and Torreilles J. Neurodegenerative disorders: the role of peroxynitrite. Brain Res. Brain Res. Rev. 30 (1999) 153-163
25. van der Veen R.C., Hinton D.R., Incardonna F., and Hofman F.M. Extensive peroxynitrite activity during progressive stages of central nervous system inflammation. J. Neuroimmunol. 77 (1997) 1-7